Clinical Trial Update: Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

The MD Anderson Cancer Center–sponsored Phase 1/Phase 2 trial in non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN